Log in
Enquire now
Azafaros

Azafaros

Developer of therapeutics for rare lysosomal storage disorders.

OverviewStructured DataIssuesContributors
Is a
Company
Company
Organization
Organization
CEO
‌
Stefano Portolano
COO
‌
Silvia Ragno
Country
Netherlands
Netherlands
Email Address
info@azafaros.com
Founded Date
2018
Headquarters
Naarden
Naarden
Industry
Pharmaceutical industry
Pharmaceutical industry
Biotechnology
Biotechnology
Manufacturing
Manufacturing
Health technology
Health technology
Investors
BioMedPartners
BioMedPartners
0
Jeito Capital
Jeito Capital
The Pictet Group
The Pictet Group
Forbion Capital Partners
Forbion Capital Partners
Seroba Life Science
Seroba Life Science
BioGeneration Ventures
BioGeneration Ventures
‌
Schroders Capital
Latest Funding Round Date
May 13, 2025
Latest Funding Round Amount (USD)
147,000,000
Latest Funding Type
Series B
Series B
LinkedIn URL
@company/37801478
Location
Switzerland
Switzerland
Netherlands
Netherlands
Number of Employees (Ranges)
11 – 50
Total Funding Amount (USD)
174,500,000
Official Website
azafaros.com

Find more companies like Azafaros

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.